When to test for parasitic infections before beginning treatment with biologics in patients with CRSwNP?
Laryngo-rhino-otologie(2022)
摘要
The development of type-2 biologics allows successfull treatment of patients with recurring, severe chronic rhinosinusitis with nasal polyps. The selective effect mechanism of biologics also targets the part of our immunosystem, that contributes to our physiological defense against parasitic diseases.
更多查看译文
关键词
parasitic infections,crswnp,biologics,patients
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要